Decreased Expression of the DNA Mismatch Repair Gene Mlh1 under Hypoxic Stress in Mammalian Cells

REFERENCES

• Avila, M. A., M. V. Carretero, E. N. Rodriguez, and J. M. Mato. 1998. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 114: 364–371.
   PubMedGoogle Scholar
• Baker, S. M., A. W. Plug, T. A. Prolla, C. E. Bronner, A. C. Harris, X. Yao, D. M. Christie, C. Monell, N. Arnheim, A. Bradley, T. Ashley, and R. M. Liskay. 1996. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat. Genet. 13: 336–342.
   PubMed Web of Science ®Google Scholar
• Baylin, S. B., M. Esteller, M. R. Rountree, K. E. Bachman, K. Schuebel, and J. G. Herman. 2001. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10: 687–692.
   PubMed Web of Science ®Google Scholar
• Berk, J. L., N. Massoomi, C. Hatch, and R. H. Goldstein. 1999. Hypoxia downregulates tropoelastin gene expression in rat lung fibroblasts by pretranslational mechanisms. Am. J. Physiol. 277: L566–572.
   PubMed Web of Science ®Google Scholar
• Brizel, D. M., S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz, and M. W. Dewhirst. 1996. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56: 941–943.
   PubMed Web of Science ®Google Scholar
• Bruick, R. K., and S. L. McKnight. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337–1340.
   PubMed Web of Science ®Google Scholar
• Bunn, H. F., and R. O. Poyton. 1996. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76: 839–885.
   PubMed Web of Science ®Google Scholar
• Chang, D. K., L. Ricciardiello, A. Goel, C. L. Chang, and C. R. Boland. 2000. Steady-state regulation of the human DNA mismatch repair system. J. Biol. Chem. 275: 18424–18431.
   PubMed Web of Science ®Google Scholar
• Chen, R. Z., U. Pettersson, C. Beard, L. Jackson-Grusby, and R. Jaenisch. 1998. DNA hypomethylation leads to elevated mutation rates. Nature 395: 89–93.
   PubMed Web of Science ®Google Scholar
• Chen, S., S. H. Bigner, and P. Modrich. 2001. High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc. Natl. Acad. Sci. USA 98: 13802–13807.
   PubMedGoogle Scholar
• Coquelle, A., F. Toledo, S. Stern, A. Bieth, and M. Debatisse. 1998. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2: 259–265.
   PubMedGoogle Scholar
• Foster, P. L., and J. Cairns. 1992. Mechanisms of directed mutation. Genetics 131: 783–789.
   PubMedGoogle Scholar
• Fritzell, J. A., L. Narayanan, S. M. Baker, C. E. Bronner, S. E. Andrew, T. A. Prolla, A. Bradley, F. R. Jirik, R. M. Liskay, and P. M. Glazer. 1997. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res. 57: 5143–5147.
   PubMedGoogle Scholar
• Goldberg, M. A., S. P. Dunning, and H. F. Bunn. 1988. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242: 1412–1415.
   PubMed Web of Science ®Google Scholar
• Gunther, E. J., N. E. Murray, and P. M. Glazer. 1993. High efficiency, restriction-deficient in vitro packaging extracts for bacteriophage lambda DNA using a new E. coli lysogen. Nucleic Acids Res. 21: 3903–3904.
   PubMed Web of Science ®Google Scholar
• Herman, J. G., A. Umar, K. Polyak, J. R. Graff, N. Ahuja, J. P. Issa, S. Markowitz, J. K. Willson, S. R. Hamilton, K. W. Kinzler, M. F. Kane, R. D. Kolodner, B. Vogelstein, T. A. Kunkel, and S. B. Baylin. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95: 6870–6875.
   PubMed Web of Science ®Google Scholar
• Hockel, M., K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel. 1996. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56: 4509–4515.
   PubMed Web of Science ®Google Scholar
• Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253: 49–53.
   PubMed Web of Science ®Google Scholar
• Ito, E., Y. Yanagisawa, Y. Iwahashi, Y. Suzuki, H. Nagasaki, Y. Akiyama, S. Sugano, Y. Yuasa, and K. Maruyama. 1999. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem. Biophys. Res. Commun. 256: 488–494.
   PubMedGoogle Scholar
• Ivan, M., K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane, and W. G. Kaelin, Jr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292: 464–468.
   PubMed Web of Science ®Google Scholar
• Jaakkola, P., D. R. Mole, Y. M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, A. Kriegsheim, H. F. Hebestreit, M. Mukherji, C. J. Schofield, P. H. Maxwell, C. W. Pugh, and P. J. Ratcliffe. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468–472.
   PubMed Web of Science ®Google Scholar
• Kane, M. F., M. Loda, G. M. Gaida, J. Lipman, R. Mishra, H. Goldman, J. M. Jessup, and R. Kolodner. 1997. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57: 808–811.
   PubMed Web of Science ®Google Scholar
• Kim, M. S., H. J. Kwon, Y. M. Lee, J. H. Baek, J. E. Jang, S. W. Lee, E. J. Moon, H. S. Kim, S. K. Lee, H. Y. Chung, C. W. Kim, and K. W. Kim. 2001. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat. Med. 7: 437–443.
   PubMed Web of Science ®Google Scholar
• Kolodner, R. 1996. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10: 1433–1442.
   PubMed Web of Science ®Google Scholar
• Koong, A. C., N. C. Denko, K. M. Hudson, C. Schindler, L. Swiersz, C. Koch, S. Evans, H. Ibrahim, Q. T. Le, D. J. Terris, and A. J. Giaccia. 2000. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60: 883–887.
   PubMed Web of Science ®Google Scholar
• Loeb, L. A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51: 3075–3079.
   PubMed Web of Science ®Google Scholar
• Marks, P. A., V. M. Richon, and R. A. Rifkind. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92: 1210–1216.
   PubMed Web of Science ®Google Scholar
• Minchenko, A., S. Salceda, T. Bauer, and J. Caro. 1994. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res. 40: 35–39.
   PubMedGoogle Scholar
• Modrich, P., and R. Lahue. 1996. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65: 101–133.
   PubMed Web of Science ®Google Scholar
• Nair, A. R., L. J. Boersma, L. Schiltz, M. A. Chaudhry, R. J. Muschel, and A. Chaudry. 2001. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. Cancer Lett. 166: 55–64.
   PubMedGoogle Scholar
• Narayanan, L., J. A. Fritzell, S. M. Baker, R. M. Liskay, and P. M. Glazer. 1997. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc. Natl. Acad. Sci. USA 94: 3122–3127.
   PubMed Web of Science ®Google Scholar
• Paquette, B., and J. B. Little. 1994. In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by X-rays. Cancer Res. 54: 3173–3178.
   PubMed Web of Science ®Google Scholar
• Parsons, R., G. M. Li, M. J. Longley, W. H. Fang, N. Papadopoulos, J. Jen, A. de la Chapelle, K. W. Kinzler, B. Vogelstein, and P. Modrich. 1993. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75: 1227–1236.
   PubMed Web of Science ®Google Scholar
• Peretz, S., R. Jensen, R. Baserga, and P. M. Glazer. 2001. ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc. Natl. Acad. Sci. USA 98: 1676–1681.
   PubMed Web of Science ®Google Scholar
• Reisdorph, R., and R. Lindahl. 1998. Hypoxia exerts cell-type-specific effects on expression of the class 3 aldehyde dehydrogenase gene. Biochem. Biophys. Res. Commun. 249: 709–712.
   PubMed Web of Science ®Google Scholar
• Reynolds, T. Y., S. Rockwell, and P. M. Glazer. 1996. Genetic instability induced by the tumor microenvironment. Cancer Res. 56: 5754–5757.
   PubMed Web of Science ®Google Scholar
• Rice, G. C., C. Hoy, and R. T. Schimke. 1986. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 83: 5978–5982.
   PubMed Web of Science ®Google Scholar
• Rockwell, S. 1977. In vivo-in vitro tumor systems: new models for studying the response of tumours to therapy. Lab. Anim. Sci. 27: 831–851.
   PubMedGoogle Scholar
• Rockwell, S. 1997. Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol. Res. 9: 383–390.
   PubMedGoogle Scholar
• Rosenberg, S. M. 2001. Evolving responsively: adaptive mutation. Nat. Rev. Genet. 2: 504–515.
   PubMed Web of Science ®Google Scholar
• Rountree, M. R., K. E. Bachman, J. G. Herman, and S. B. Baylin. 2001. DNA methylation, chromatin inheritance, and cancer. Oncogene 20: 3156–3165.
   PubMed Web of Science ®Google Scholar
• Ryan, H. E., M. Poloni, W. McNulty, D. Elson, M. Gassmann, J. M. Arbeit, and R. S. Johnson. 2000. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60: 4010–4015.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem. Pharmacol. 59: 47–53.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2000. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88: 1474–1480.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2001. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107: 1–3.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L. 2000. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit. Rev. Biochem. Mol. Biol. 35: 71–103.
   PubMed Web of Science ®Google Scholar
• Sook Kim, M., J. Hyen Baek, M. K. Bae, and K. W. Kim. 2001. Human rad21 gene, hHR21(SP), is downregulated by hypoxia in human tumor cells. Biochem. Biophys. Res. Commun. 281: 1106–1112.
   PubMedGoogle Scholar
• Strand, M., T. A. Prolla, R. M. Liskay, and T. D. Petes. 1993. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365: 274–276. (Erratum, 368: 569, 1994.)
   PubMed Web of Science ®Google Scholar
• Sutherland, R. M. 1998. Tumor hypoxia and gene expression—implications for malignant progression and therapy. Acta Oncol. 37: 567–574.
   PubMed Web of Science ®Google Scholar
• Wang, G., D. D. Levy, M. M. Seidman, and P. M. Glazer. 1995. Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol. Cell. Biol. 15: 1759–1768.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., and G. L. Semenza. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268: 21513–21518.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., and G. L. Semenza. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82: 3610–3615.
   PubMed Web of Science ®Google Scholar
• Warren, S. M., D. S. Steinbrech, B. J. Mehrara, P. B. Saadeh, J. A. Greenwald, J. A. Spector, P. J. Bouletreau, and M. T. Longaker. 2001. Hypoxia regulates osteoblast gene expression. J. Surg. Res. 99: 147–155.
   PubMed Web of Science ®Google Scholar
• Wilkinson, D., J. K. Sandhu, J. W. Breneman, J. D. Tucker, and H. C. Birnboim. 1995. Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. Br. J. Cancer 72: 1234–1240.
   PubMed Web of Science ®Google Scholar
• Williams, K. J., R. L. Cowen, and I. J. Stratford. 2001. Hypoxia and oxidative stress. Tumour hypoxia—therapeutic considerations. Breast Cancer Res. 3: 328–331.
   PubMedGoogle Scholar
• Wood, R. D. 1996. DNA repair in eukaryotes. Annu. Rev. Biochem. 65: 135–167.
   PubMed Web of Science ®Google Scholar
• Xiong, Z., and P. W. Laird. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25: 2532–2534.
   PubMed Web of Science ®Google Scholar
• Yao, X., A. B. Buermeyer, L. Narayanan, D. Tran, S. M. Baker, T. A. Prolla, P. M. Glazer, R. M. Liskay, and N. Arnheim. 1999. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc. Natl. Acad. Sci. USA 96: 6850–6855.
   PubMedGoogle Scholar
• Yoshida, M., M. Kijima, M. Akita, and T. Beppu. 1990. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265: 17174–17179.
   Google Scholar
• Young, S. D., R. S. Marshall, and R. P. Hill. 1988. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 85: 9533–9537.
   PubMed Web of Science ®Google Scholar
• Yuan, J., and P. M. Glazer. 1998. Mutagenesis induced by the tumor microenvironment. Mutat. Res. 400: 439–446.
   PubMed Web of Science ®Google Scholar
• Yuan, J., L. Narayanan, S. Rockwell, and P. M. Glazer. 2000. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res. 60: 4372–4376.
   PubMed Web of Science ®Google Scholar
• Zhu, H., and H. F. Bunn. 2001. Signal transduction. How do cells sense oxygen? Science 292: 449–451.
   PubMed Web of Science ®Google Scholar